Page 2 - ர்ப் மூலதனம் கூட்டாளர்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ர்ப் மூலதனம் கூட்டாளர்கள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ர்ப் மூலதனம் கூட்டாளர்கள் இன்க் Today - Breaking & Trending Today

Sunshine Biopharma (Stock Symbol: SBFM) Taking Leading Steps on Virus and Cancer Treatments. 2 Million financing placed

Sunshine Biopharma (#Stock Symbol: $SBFM) Taking Leading Steps on #Virus #Covid #Cancer #Treatments $2 Million Financing in Place, Uplisting to OTCQB Tier ....

United States , United Kingdom , Pointe Claire , Camille Sebaaly , Frontpagestocks Corporateads , Financing For Coronavirus Treatment Program , University Of Georgia , Sunshine Biopharma Inc , Canadian Intellectual Property Office , College Of Pharmacy , Biopharma Company , Rb Capital Partners Inc , Stock Symbol , Taking Leading Steps , Worldwide Patents , Effective Cancer , Joint Agreement , Advance Cancer Treatment , Clinical Trials , Transgenic Mice Study Underway , Covid Treatment Expected , Effective Against New Virus , Application Completed , Coronavirus Treatment , Multidrug Resistant Cancer Cells , Pancreatic Cancer ,

Sunshine Biopharma Inc.: Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment

(2)
MONTREAL, QC / ACCESSWIRE / January 14, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received the fourth tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $1,050,000 that the Company has received to date under this financing. The proceeds will be used for the ongoing development of the Company s Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the Company s flagship anticancer compound targeted for pancreatic cancer.
Sunshine Biopharma Inc. CFO, Camille Sebaaly stated, As a company, we continue to forge forward in our development of a COVID treatment and our anticancer compounds. This investment capital has been integral to our progress in each of these sectors. ....

Deborah Braun , Brett Rosen , Kostenloser Wertpapierhandel , Camille Sebaaly , Mcgill University Jewish , Company Coronavirus Treatment , University Of Georgia , Exchange Commission , Sunshine Biopharma Inc , College Of Pharmacy , Rb Capital Partners Inc , Sunshine Biopharma , Coronavirus Treatment , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , Bio Pharma , Corona Virus , டெபோரா மூளை , ப்ரெட் ரோஸன் ,

Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment

Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Deborah Braun , Brett Rosen , Camille Sebaaly , Mcgill University Jewish , Company Coronavirus Treatment , University Of Georgia , Exchange Commission , Sunshine Biopharma Inc , College Of Pharmacy , Rb Capital Partners Inc , Sunshine Biopharma , Coronavirus Treatment , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , டெபோரா மூளை , ப்ரெட் ரோஸன் , மகில் பல்கலைக்கழகம் நகை , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , பரிமாற்றம் தரகு ,

ResGreen Group International Inc.: Resgreen Group International, Inc. Signs Letter of Intent with RB Capital Partners, Inc.

ResGreen Group International Inc.: Resgreen Group International, Inc. Signs Letter of Intent with RB Capital Partners, Inc.
, a leading mobile robot company,
today announced that it has executed on a signed letter of intent with California based RB Capital Partners, Inc. ( RB Capital ) to receive $500,000+ of financing over the next six months. The Company has already received the first tranche of $100,000 from RB Capital as the demand for its UV-C products and Autonomous Mobile Robot (AMR) is growing.
Much of this funding is dedicated to the purchase of inventory needed to finish assembly of the Wanda II and Pull Buddy orders, as well as to prepare additional equipment inventory for impending sales that are anticipated from the early interest we have received. ....

United States , Parsh Patel , Sarah Carlson , Parashar Parsh Patel , Michigan Newsfile Corp , Resgreen Group International Inc , Resgreen Group , Rb Capital Partners Inc , Clinton Township , Group International , Autonomous Mobile Robot , Pull Buddy , Resgreen Group International , Artificial Intelligence Robotics , Autonomous Mobile Robots , Automatic Guided Vehicles , Harbor Statement , Private Securities Litigation Reform Act , Green Group International , ஒன்றுபட்டது மாநிலங்களில் , பாகுபடுத்தி படேல் , சாரா கார்ல்சன் , பராஷர் பாகுபடுத்தி படேல் , ர்ப் மூலதனம் கூட்டாளர்கள் இன்க் , கிளின்டன் டவுன்ஷிப் , குழு சர்வதேச ,